Skip to main content
. 2022 Feb 11;19(2):154–165. doi: 10.1007/s11904-022-00601-5

Table 1.

Study characteristics, according to HIV prevalence [21]

Total
(N=71)
Low HIV prevalence1 (N=52) High HIV prevalence1 (N=19)
Country income level* n (%) n (%) n (%)
High 36 (51) 36 (69) 0 (0)
Middle 33 (46) 15 (29) 18 (95)
Low 6 (8) 1 (2) 5 (26)
Settings
Primary care 17 (24) 7 (13) 10 (53)
Hospital 13 (18) 10 (19) 3 (16)
Emergency department 11 (15) 11 (21) 0 (0)
Community 8 (11) 8 (15) 0 (0)
STI clinic 5 (7) 4 (8) 1 (5)
Antenatal or maternity ward 4 (6) 1 (2) 3 (16)
Prisons 2 (3) 2 (4) 0 (0)
Populations
MSM 15 (21) 15 (29) 0 (0)
Paediatrics 14 (20) 6 (12) 8 (42)
Primary care attendees 11 (15) 11 (21) 0 (0)
Emergency department attendees 11 (15) 11 (21) 0 (0)
Women 8 (11) 1 (2) 7 (37)
Hospital inpatients 6 (8) 5 (10) 1 (5)
Adults in the community 3 (4) 1 (2) 2 (11)
STI clinic attendees 3 (4) 2 (4) 1 (5)
Incarcerated persons 2 (3) 2 (4) 0 (0)
Serodiscordant couples 2 (3) 1 (2) 1 (5)
People who inject drugs 1 (1) 1 (2) 0 (0)
Female sex workers 1 (1) 0 (0) 1 (5)
Tool administered by
Patient 13 (18) 6 (12) 7 (37)
Provider 42 (52) 26 (50) 16 (84)
Type of tool
Screening in 50 (70) 38 (73) 12 (63)
Screening out 21 (30) 14 (27) 7 (37)

*Some studies contain more than one country, so the denominator may not add up to 71. The number of missing studies is not shown

1High HIV prevalence is defined as ≥5%, and low HIV prevalence is defined as <5%